COXSACKIE VIRUS B1-B6 CF ANTIGENS— 510(k) K921618

Substantially Equivalent

Virion (U.S.), Inc.

FDA 510(k) clearance K921618 for COXSACKIE VIRUS B1-B6 CF ANTIGENS, Substantially Equivalent on 1992-06-29. Applicant: Virion (U.S.), Inc..

Clearance details

Applicant: Virion (U.S.), Inc.
Product code: Code GNG
Advisory panel: Microbiology
Date received: 1992-04-06
Decision date: 1992-06-29
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Morristown, NJ, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.